27 Dec, 09:59 - Indian

SENSEX 78983.2 (0.65)

Nifty 50 23918.400390625 (0.71)

Nifty Bank 51502.5 (0.65)

Nifty IT 43789.6015625 (0.29)

Nifty Midcap 100 57211.8515625 (0.15)

Nifty Next 50 69388.1015625 (0.32)

Nifty Pharma 22908.69921875 (0.86)

Nifty Smallcap 100 18746.599609375 (0.10)

27 Dec, 09:59 - Global

NIKKEI 225 40288.29 (1.82)

HANG SENG 20121.8 (0.12)

S&P 6096.25 (-0.18)

Cancel

BSE Code : 532296 | NSE Symbol : GLENMARK | ISIN : INE935A01035 | Industry : Pharmaceuticals |

(16-Dec-24 09:41) Glenmark Pharma arm launches seizure drug in US
(16-Dec-24 09:06) Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
(03-Dec-24 13:06) Glenmark Pharmaceuticals Ltd up for third straight session
(27-Nov-24 09:59) Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market
(27-Nov-24 09:12) Glenmark Pharma launches Travoprost Ophthalmic Solution USP
(18-Nov-24 13:35) Glenmark Pharmaceuticals Ltd eases for fifth straight session
(15-Nov-24 14:40) Glenmark Pharma reports turnaround Q2 results
(15-Nov-24 09:56) Glenmark Pharmaceuticals reports consolidated net profit of Rs 354.21 crore in the September 2024 quarter
(15-Nov-24 07:42) Glenmark Pharmaceuticals standalone net profit rises 96.81% in the September 2024 quarter
(06-Nov-24 13:05) Glenmark Pharmaceuticals Ltd gains for third straight session

1 2 3 4 5 6 7 8 9 10

Glenmark Pharmaceuticals Ltd